Featured Insights

1. Navigating Global Health Policy In A Time Of Disruption 8/12/2025

   The healthcare industries in the U.S. and EU are undergoing significant regulatory and legislative changes. Learn how to better position yourself to navigate this complex environment.

2. Patient Empowerment Through The European Health Data Space (EHDS) 8/12/2025

   A new regulation in the EU will give patients more control over their health data. Discover the opportunities and challenges this shift presents for the future of patient-centric healthcare.

3. Unlocking Innovation: New Models And Next-Gen Tech For Success 8/12/2025

   AI and digital innovation are reshaping the pharmaceutical landscape. Learn how the industry is leveraging data and technology to enhance commercialization and improve patient outcomes.

4. Enhancing The Biosimilar Review Process 8/12/2025

   The biosimilar market is projected to reach over $100 billion in the next five years. Learn how to navigate the expanding landscape and overcome challenges in accessing key clinical information.

5. How PIE Streamlines Biopharma And Payer Communication 8/12/2025

   Navigating pre-approval information exchange (PIE) with healthcare decision-makers is essential for market success. Learn what information can be shared and the best strategies for communication.

6. How Digital Twins And Hybrid Modelling Optimize Cell Culture Process For Better Production 7/14/2025

   Discover how digital twins are enabling the optimization of cell culture processes for improved, more predictable outcomes in the creation of therapeutic proteins and antibodies.

7. FDA Expands Unannounced Foreign Manufacturing Inspections 7/9/2025

   Unannounced FDA inspections are now the norm for foreign manufacturers. Learn how this pivotal shift impacts global drug, biologic, and device companies and how to prepare.

8. Advancing Sterile Manufacturing: A Strategic Imperative For Modern Pharmaceutical Production 7/9/2025

   Ensuring sterile drug production is vital for patient health and a key regulatory focus. Discover core principles and emerging trends in sterile manufacturing.

9. HTA In Japan: The Glass Remains Half Full (For Now) 6/12/2025

   While Japan's current HTA system is seen as pro-innovation, potential reforms in 2026 could expand its scope, creating uncertainty for manufacturers in one of the world's largest markets.

10. Early Access Program In France: How Much Of An Opportunity Is It? 6/12/2025

    Navigating France’s Early Access Program is more complex than ever. Amid declining approval rates and mandatory data collection, here’s what pharmaceutical companies need to know about the changing landscape.